Amgen Investor

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Technology: CAR-T, Cell_Therapies, Space Medicine
Industry: AI, Pharma
Headquarters: Thousand Oaks, California, United States
Founded Date: 1980-01-01
Employees Number: 10001+
Funding Status: IPO
Investor Type: Undisclosed
Investment Stage: N/A
Number Of Exits: 7
Acquisitions Number: Made Acquisitions
Investors Number: 2
Total Funding: 28500000000
Estimated Revenue: $10B+
Last Funding Date: 2022-12-12
Last Funding Type: Post-IPO Debt

Visit Website
amgenmediarelations@amgen.com
https://twitter.com/amgen
Register and Claim Ownership
Suggested by Amgen